EydisBio, Inc.
PrivateLast Round
Grant
Oct 23, 2024
Total Funding Raised
$3.67M
Company Overview
EydisBio, Inc. operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Grant round in October 2024.
EydisBio, Inc. is a biotechnology company that develops small molecule kinase inhibitors for the treatment of autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EydisBio, Inc. Comparables
Compare EydisBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AQILION AB | 79% | |
| Mysthera Therapeutics AG | 78% | |
| Matchpoint Therapeutics | 78% |
For institutional investors. Book with your work email.
EydisBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 23, 2024 | ||||
| Grant | Aug 28, 2024 | ||||
| Grant | Sep 18, 2019 |
For institutional investors. Book with your work email.
EydisBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| National Institute on Aging | Grant |
| North Carolina Biotechnology Center | Debt, Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 440% MoM, from 297 to 1.6K.
- Nov 8, 2025
Monthly visitors grew 140% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
EydisBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EydisBio, Inc.'s valuation, stock price, and market status.
Is EydisBio, Inc. a public or private company?
EydisBio, Inc. is a private company.
What is the current stock price of EydisBio, Inc.?
EydisBio, Inc. is a private company, so its shares have no public market price. Caplight tracks EydisBio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EydisBio, Inc. worth (valuation)?
Valuation information for EydisBio, Inc. is not publicly available.
Can I buy EydisBio, Inc. stock?
EydisBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EydisBio, Inc.'s last funding round?
EydisBio, Inc.'s most recent funding round was Grant on October 23, 2024.
Who are the main investors in EydisBio, Inc.?
Key investors in EydisBio, Inc. include National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, North Carolina Biotechnology Center, National Heart, Lung, and Blood Institute.
Will EydisBio, Inc. IPO soon?
No public IPO plans have been announced for EydisBio, Inc..
How can I track EydisBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in EydisBio, Inc.'s shares on secondary markets.